maaf email atau password anda salah

Satu Akun, Untuk Semua Akses

Forgot Password ? Click Here

atau Masuk melalui

Google

Belum Memiliki Akun Daftar di Sini

Satu Akun, Untuk Semua Akses


Have an account? Log in here

Konfirmasi Email

Kami telah mengirimkan link aktivasi melalui email ke rudihamdani@gmail.com.

Klik link aktivasi dan dapatkan akses membaca 2 artikel gratis non Laput di koran dan Majalah Tempo

Jika Anda tidak menerima email,
Kirimkan Lagi Sekarang

Satu Akun, Untuk Semua Akses

Enter your email, untuk mereset password

Konfirmasi Email

Kami telah mengirimkan link reset password melalui email ke rudihamdani@gmail.com.

Ubah No. Telepon

Ubah Password

Topik Favorit

Hapus Berita

Apakah Anda yakin akan menghapus berita?

Ubah Data Diri

Jenis Kelamin

Nanobody Cure for Autoimmune Diseases

Monday, April 25, 2022

Novalia Pisesha invents an effective and affordable medical technology. University and post-graduate students look to her to study nanobody technology in curing autoimmune diseases.

arsip tempo : 170145627641.

Novalia Pisesha Rhogerry Deshycka . tempo : 170145627641.

IN her 15 years living in the United States, Novalia Pisesha always carried with her the promise she made to her aunt suffering from lupus. Her academic path in bioengineering started at the City College of San Francisco (CCSF) in California. Her dream was to find a proper cure for autoimmune diseases. “I promised my aunt that I would invent an effective medicine,” she said through a video conference call on Wednesday, April 20.  

...

Subscribe to continue reading.
We craft news with stories.

For the benefits of subscribing to Digital Tempo, See More

The Best Choice

Rp 54.945/Month

Active for 12 Months, Rp 659.340

  • *You Save -Rp 102.000
  • *Guaranteed update of up to 52 Editions of Tempo Magazine

Rp 64.380/Month

Active Every Month Cancel Anytime

  • *Free for the first month if using a Credit Card

See Other Packages

Already a Subscribed? Log in here
To receive daily news by Email, Sign up for Tempo ID.

More Articles

More exclusive contents

  • November 27, 2023

  • November 20, 2023

  • November 13, 2023

  • November 6, 2023

Independent journalism needs public support. By subscribing to Tempo, you will contribute to our ongoing efforts to produce accurate, in-depth and reliable information. We believe that you and everyone else can make all the right decisions if you receive correct and complete information. For this reason, since its establishment on March 6, 1971, Tempo has been and will always be committed to hard-hitting investigative journalism. For the public and the Republic.

Login Subscribe